GUSI introduces Sage AI tool for ultrasound learners

AuntMinnie.com staff writers
Sep 17, 2024

The Global Ultrasound Institute (GUSI) has released Sage AI, an AI tool that answers open-ended ultrasound-related questions.

Sage AI adds to GUSI's scanHub training platform, which aims to help healthcare practitioners gain competency in using point-of-care ultrasound (POCUS) across a range of medical specialties. Answers given by Sage AI are fully referenced, are accompanied by ultrasound images and video clips drawn from GUSI's pathology library, and can be delivered in more than 80 different languages.

Sage AI incorporates the GUSI's library of educational assets, which includes course materials, videos, images, and teaching sessions. The GUSI has incorporated a curated list of knowledge sources for POCUS.

Sage AI is currently available free of charge for all registered users of globalultrasoundinstitute.com.

Latest in Ultrasound
Baby Bottle
Could cranial ultrasound sub for brain MRI in imaging infants?
November 6, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
Ultrasound nonmass breast lesion features may signal malignancy
November 5, 2024
Chat Gpt 400
ChatGPT demonstrates mixed results in assigning BI-RADS categories
November 1, 2024
Ultrasound Breast 400
ABUS screening improves breast cancer screening in low-resource areas
October 29, 2024
Related Stories
Ultrasound In Africa
Ultrasound
Butterfly and partners collaborate on maternal health in South Africa
Doctor Virtual Meeting Laptop Computer Social
POCUS
Butterfly Network launches 2 new education offerings
2022 09 14 16 01 8906 Ultrasound In Africa 400
Ultrasound
Butterfly Network distributes handheld ultrasound units in Kenya
Ceus Vi Rads 09 10 2024 Rsna Thumbnail V2
Ultrasound
Researchers develop a CEUS bladder cancer scoring metric
More in Ultrasound
Could cranial ultrasound sub for brain MRI in imaging infants?
By Amerigo Allegretto
Cranial ultrasound could have utility for imaging infants with hypoxic-ischemic encephalopathy.
November 6, 2024
Baby Bottle
Ultrasound nonmass breast lesion features may signal malignancy
By Amerigo Allegretto
Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.
November 5, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
ChatGPT demonstrates mixed results in assigning BI-RADS categories
By Amerigo Allegretto
ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.
November 1, 2024
Chat Gpt 400
ABUS screening improves breast cancer screening in low-resource areas
By Amerigo Allegretto
Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.
October 29, 2024
Ultrasound Breast 400
Ukraine's top pediatric hospital rebuilds after bomb attack
By Philip Ward
Radiology staff at the Ohmatdyt Children's Hospital in Kyiv are making steady progress with their plan to restore normal service after a devastating missile attack.
October 25, 2024
Thanks to the support of the global imaging community, radiology staff at the Ohmatdyt can now look forward to restoring normal service.
CNN models using ultrasound images detect pancreatic neoplasms
By Amerigo Allegretto
A deep-learning method using endoscopic ultrasound images could detect pancreatic neuroendocrine neoplasms.
October 18, 2024
Ultrasound Scanner Computerized 400
Ultrasound method detects cellular rejection in liver transplant cases
By Amerigo Allegretto
An ultrasound measurement technique could detect and stage acute cellular rejection in liver transplant patients.
October 16, 2024
Ultrasound Diagnostic Control Panel
Could elastography replace conventional ultrasound-guided FNAC?
By Amerigo Allegretto
Strain elastography does not have additional benefits over conventional elastography-guided FNAC for diagnosing malignancy in thyroid nodules.
October 15, 2024
Images depict a 43-year-old woman with a solitary left-sided thyroid nodule classified at gray-scale ultrasound as category U3, upgraded to category U4 at strain elastography, and classified as category Thy4 at cytopathologic examination. Subsequent surgical histopathologic examination confirmed papillary cell carcinoma. (A) Longitudinal view of the left thyroid lobe demonstrates the low reflective nodule (between arrows) measuring 13 × 12 × 11 mm (not shown) and with a halo. (B) A longitudinal image with side-by-side visualization of the nodule (arrow) at gray scale (left) and strain elastography (right). The nodule is predominantly blue, indicating increased stiffness. (C) A longitudinal view shows the needle (arrows) within the stiffer aspect of the nodule for cytology sampling. U and Thy categories are according to British Thyroid Association system. Image courtesy of the RSNA.
Ultrasound test detects 96% of ovarian cancers
By Kate Madden Yee
An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.
October 1, 2024
Ovarian Cancer
Publicly insured pregnant women less likely to get 20-week ultrasounds
By Amerigo Allegretto
Twenty-week ultrasound exams for pregnant women drives disparities in prenatal diagnosis of congenital heart defects.
September 23, 2024
Fetal Ultrasound
Lung ultrasound underdiagnoses pneumothorax in trauma patients
By Amerigo Allegretto
Lung ultrasound underdiagnoses clinically significant pneumothorax on initial trauma evaluation.
September 20, 2024
Ultrasound Probe Vascular
Dedicated ultrasound, MRI protocols improve endometriosis diagnosis
By Kate Madden Yee
Dedicated ultrasound and MRI protocols -- in contrast to routine ones -- are more effective in diagnosing endometriosis, researchers have reported.
September 13, 2024
Ultrasound Transducer3
Page 1 of 512
Next Page